10-Q/A Filing

Astrana Health, Inc. CIK: 1083446 Q1 2015

Filing Information

Form Type	10-Q/A
Accession Number	`0001144204-15-052743`
Period End Date	20150630
Filing Date	20150828
Fiscal Year	2015
Fiscal Period	Q1
XBRL Instance	ameh-20150630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 84 Income Statement 38 Cash Flow Statement 60

Balance Sheet 84 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.01M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.89M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.76M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$6.83M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$3.80M	USD	Point-in-time
Common Stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$3.69M	USD	Point-in-time
Other receivables	`AccountsAndOtherReceivablesNetCurrent`	$328.44K	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Other receivables	`AccountsAndOtherReceivablesNetCurrent`	$208.29K	USD	Point-in-time
Due from Affiliates	`DueFromAffiliateCurrent`	$36.40K	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	4.86M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	4.86M	shares	Point-in-time
Due from Affiliates	`DueFromAffiliateCurrent`	$30.61K	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	4.86M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$278.92K	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	4.86M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$258.22K	USD	Point-in-time
Deferred financing costs, net, current	`DeferredFinanceCostsCurrentNet`	$513.65K	USD	Point-in-time
Deferred financing costs, net, current	`DeferredFinanceCostsCurrentNet`	-	USD	Point-in-time
Total current assets	`AssetsCurrent`	$8.20M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$9.85M	USD	Point-in-time
Deferred financing costs, net, non-current	`DeferredFinanceCostsNoncurrentNet`	$264.71K	USD	Point-in-time
Deferred financing costs, net, non-current	`DeferredFinanceCostsNoncurrentNet`	$235.09K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$577.27K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$582.47K	USD	Point-in-time
Restricted cash	`RestrictedCashAndInvestmentsCurrent`	$530.00K	USD	Point-in-time
Restricted cash	`RestrictedCashAndInvestmentsCurrent`	$530.00K	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$1.34M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$1.38M	USD	Point-in-time
Goodwill	`Goodwill`	$2.17M	USD	Point-in-time
Goodwill	`Goodwill`	$2.17M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$218.72K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$212.15K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$15.00M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$13.26M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$3.35M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$4.14M	USD	Point-in-time
Medical liabilities	`MedicalLiabilitiesCurrent`	$1.26M	USD	Point-in-time
Medical liabilities	`MedicalLiabilitiesCurrent`	$1.15M	USD	Point-in-time
Note and line of credit payable, net of discount, current portion	`NotesAndLinesOfCreditPayableCurrent`	$6.62M	USD	Point-in-time
Note and line of credit payable, net of discount, current portion	`NotesAndLinesOfCreditPayableCurrent`	$327.14K	USD	Point-in-time
Convertible notes payable, net of discount, current portion	`ConvertibleNotesPayableCurrent`	$2.60M	USD	Point-in-time
Convertible notes payable, net of discount, current portion	`ConvertibleNotesPayableCurrent`	$1.04M	USD	Point-in-time
Warrant liability	`DerivativeLiabilitiesCurrent`	$2.31M	USD	Point-in-time
Warrant liability	`DerivativeLiabilitiesCurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$16.82M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.98M	USD	Point-in-time
Notes payable, net of discount, non-current portion	`LongTermNotesPayable`	-	USD	Point-in-time
Notes payable, net of discount, non-current portion	`LongTermNotesPayable`	$6.23M	USD	Point-in-time
Convertible notes payable, net of discount	`ConvertibleLongTermNotesPayable`	$1.46M	USD	Point-in-time
Convertible notes payable, net of discount	`ConvertibleLongTermNotesPayable`	-	USD	Point-in-time
Warrant liability	`DerivativeLiabilitiesNoncurrent`	$2.14M	USD	Point-in-time
Warrant liability	`DerivativeLiabilitiesNoncurrent`	-	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilities`	$174.28K	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilities`	$171.22K	USD	Point-in-time
Total liabilities	`Liabilities`	$17.00M	USD	Point-in-time
Total liabilities	`Liabilities`	$15.99M	USD	Point-in-time
COMMITMENTS AND CONTINGENCIES (NOTE 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
COMMITMENTS AND CONTINGENCIES (NOTE 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, par value $0.001; 5,000,000 shares authorized; none issued	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.001; 5,000,000 shares authorized; none issued	`PreferredStockValue`	-	USD	Point-in-time
Common Stock, par value $0.001; 100,000,000 shares authorized, 4,863,389 shares issued and outstanding as of June 30, 2015 and March 31, 2015	`CommonStockValue`	$4.86K	USD	Point-in-time
Common Stock, par value $0.001; 100,000,000 shares authorized, 4,863,389 shares issued and outstanding as of June 30, 2015 and March 31, 2015	`CommonStockValue`	$4.86K	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapital`	$16.60M	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapital`	$16.52M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-19.34M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-21.82M	USD	Point-in-time
Stockholders' deficit attributable to Apollo Medical Holdings, Inc.	`StockholdersEquity`	$-5.22M	USD	Point-in-time
Stockholders' deficit attributable to Apollo Medical Holdings, Inc.	`StockholdersEquity`	$-2.82M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$1.83M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$1.48M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-3.73M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-990.18K	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	`LiabilitiesAndStockholdersEquity`	$15.00M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	`LiabilitiesAndStockholdersEquity`	$13.26M	USD	Point-in-time

Income Statement 38 line items

Line Item	Tag	Value	Unit	Period
Net revenues	`Revenues`	$4.09M	USD	1 Quarter
Net revenues	`Revenues`	$10.20M	USD	1 Quarter
Cost of services	`CostOfServices`	$3.26M	USD	1 Quarter
Cost of services	`CostOfServices`	$7.57M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.01M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$4.24M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$11.90K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$63.75K	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$11.87M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$5.28M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-1.19M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-1.66M	USD	1 Quarter
Interest expense	`InterestExpense`	$276.87K	USD	1 Quarter
Interest expense	`InterestExpense`	$360.40K	USD	1 Quarter
Change in fair value of warrant and conversion feature liability	`GainLossOnDerivativeInstrumentsNetPretax`	$-213.72K	USD	1 Quarter
Change in fair value of warrant and conversion feature liability	`GainLossOnDerivativeInstrumentsNetPretax`	$-30.00K	USD	1 Quarter
Other	`OtherNonoperatingIncomeExpense`	$101.00K	USD	1 Quarter
Other	`OtherNonoperatingIncomeExpense`	$-2.48K	USD	1 Quarter
Total other expense	`NonoperatingIncomeExpense`	$-473.12K	USD	1 Quarter
Total other expense	`NonoperatingIncomeExpense`	$-309.35K	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-1.50M	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-2.14M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$92.69K	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$11.60K	USD	1 Quarter
Net loss	`ProfitLoss`	$-1.51M	USD	1 Quarter
Net loss	`ProfitLoss`	$-2.23M	USD	1 Quarter
Net income attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$251.86K	USD	1 Quarter
Net income attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$170.21K	USD	1 Quarter
Net loss attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$-2.48M	USD	1 Quarter
Net loss attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$-1.68M	USD	1 Quarter
Unrealized change in value of marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$18.59K	USD	1 Quarter
Unrealized change in value of marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	-	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-2.48M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-1.66M	USD	1 Quarter
BASIC AND DILUTED	`EarningsPerShareBasicAndDiluted`	$-0.34	USD	1 Quarter
BASIC AND DILUTED	`EarningsPerShareBasicAndDiluted`	$-0.51	USD	1 Quarter
BASIC AND DILUTED	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	4.91M	shares	1 Quarter
BASIC AND DILUTED	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	4.86M	shares	1 Quarter

Cash Flow Statement 60 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-1.51M	USD	1 Quarter
Net loss	`ProfitLoss`	$-2.23M	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$11.90K	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$63.75K	USD	1 Quarter
Deferred income tax	`DeferredIncomeTaxExpenseBenefit`	-	USD	1 Quarter
Deferred income tax	`DeferredIncomeTaxExpenseBenefit`	$3.06K	USD	1 Quarter
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$83.85K	USD	1 Quarter
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$119.14K	USD	1 Quarter
Amortization of financing costs	`AdjustmentForAmortization`	$28.31K	USD	1 Quarter
Amortization of financing costs	`AdjustmentForAmortization`	$29.91K	USD	1 Quarter
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$115.61K	USD	1 Quarter
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$79.38K	USD	1 Quarter
Change in fair value of warrant and conversion feature liability	`GainLossOnDerivativeInstrumentsNetPretax`	$-213.72K	USD	1 Quarter
Change in fair value of warrant and conversion feature liability	`GainLossOnDerivativeInstrumentsNetPretax`	$-30.00K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-4.27K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-108.83K	USD	1 Quarter
Other receivables	`IncreaseDecreaseInOtherReceivables`	-	USD	1 Quarter
Other receivables	`IncreaseDecreaseInOtherReceivables`	$120.15K	USD	1 Quarter
Due from affiliates	`IncreaseDecreaseDueFromAffiliates`	$14.75K	USD	1 Quarter
Due from affiliates	`IncreaseDecreaseDueFromAffiliates`	$20.48K	USD	1 Quarter
Prepaid expenses and advances	`IncreaseDecreaseInPrepaidExpense`	$-20.70K	USD	1 Quarter
Prepaid expenses and advances	`IncreaseDecreaseInPrepaidExpense`	$5.27K	USD	1 Quarter
Deferred financing costs	`IncreaseDecreaseInDeferredCharges`	-	USD	1 Quarter
Deferred financing costs	`IncreaseDecreaseInDeferredCharges`	$-513.35K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-6.57K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-2.96K	USD	1 Quarter
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-4.80K	USD	1 Quarter
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$790.61K	USD	1 Quarter
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	$163.68K	USD	1 Quarter
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	$-112.90K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-1.10M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-528.35K	USD	1 Quarter
Acquisition, net of cash and cash equivalents acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	1 Quarter
Acquisition, net of cash and cash equivalents acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$-216.36K	USD	1 Quarter
Property and equipment acquired	`PaymentsToAcquirePropertyPlantAndEquipment`	$11.97K	USD	1 Quarter
Property and equipment acquired	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	1 Quarter
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$204.39K	USD	1 Quarter
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	-	USD	1 Quarter
Principal payments on term note payable	`PrincipalPaymentsOnTermNotePayable`	$175.00K	USD	1 Quarter
Principal payments on term note payable	`PrincipalPaymentsOnTermNotePayable`	-	USD	1 Quarter
Distributions to non-controlling interest shareholder	`PaymentsToMinorityShareholders`	$595.42K	USD	1 Quarter
Distributions to non-controlling interest shareholder	`PaymentsToMinorityShareholders`	-	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-595.42K	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-175.00K	USD	1 Quarter
NET DECREASE IN CASH & CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.12M	USD	1 Quarter
NET DECREASE IN CASH & CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.07M	USD	1 Quarter
CASH & CASH EQUIVALENTS, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$5.01M	USD	Point-in-time
CASH & CASH EQUIVALENTS, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$3.89M	USD	Point-in-time
CASH & CASH EQUIVALENTS, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$5.76M	USD	Point-in-time
CASH & CASH EQUIVALENTS, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$6.83M	USD	Point-in-time
CASH & CASH EQUIVALENTS, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$5.01M	USD	Point-in-time
CASH & CASH EQUIVALENTS, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$3.89M	USD	Point-in-time
CASH & CASH EQUIVALENTS, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$5.76M	USD	Point-in-time
CASH & CASH EQUIVALENTS, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$6.83M	USD	Point-in-time
Interest paid	`InterestPaid`	$150.49K	USD	1 Quarter
Interest paid	`InterestPaid`	$100.96K	USD	1 Quarter
Income taxes paid	`IncomeTaxesPaid`	$11.13K	USD	1 Quarter
Income taxes paid	`IncomeTaxesPaid`	$32.20K	USD	1 Quarter
Holdback liability	`AcquisitionRelatedHoldbackLiabilityConsideration`	-	USD	1 Quarter
Holdback liability	`AcquisitionRelatedHoldbackLiabilityConsideration`	$136.82K	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.